Title |
Cyclin A in cell cycle control and cancer
|
---|---|
Published in |
Cellular and Molecular Life Sciences, August 2002
|
DOI | 10.1007/s00018-002-8510-y |
Pubmed ID | |
Authors |
C. H. Yam, T. K. Fung, R. Y. C. Poon |
Abstract |
Cyclin A is particularly interesting among the cyclin family because it can activate two different cyclin-dependent kinases (CDKs) and functions in both S phase and mitosis. An embryonic form of cyclin A that is only essential for spermatogenesis is also present in some organisms. In S phase, phosphorylation of components of the DNA replication machinery such as CDC6 by cyclin A-CDK is believed to be important for initiation of DNA replication and to restrict the initiation to only once per cell cycle. In mitosis, the precise role of cyclin A is still obscure, but it may contribute to the control of cyclin B stability. Cyclin A starts to accumulate during S phase and is abruptly destroyed before metaphase. The synthesis of cyclin A is mainly controlled at the transcription level, involving E2F and other transcription factors. Removal of cyclin A is carried out by ubiquitin-mediated proteolysis, but whether the same anaphase-promoting complex/cyclosome targeting subunits are used as for cyclin B is debatable. Consistent with its role as a key cell cycle regulator, expression of cyclin A is found to be elevated in a variety of tumors. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Croatia | 1 | <1% |
Spain | 1 | <1% |
Unknown | 282 | 99% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 56 | 20% |
Student > Bachelor | 40 | 14% |
Unspecified | 37 | 13% |
Student > Master | 33 | 12% |
Student > Doctoral Student | 19 | 7% |
Other | 42 | 15% |
Unknown | 57 | 20% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 69 | 24% |
Biochemistry, Genetics and Molecular Biology | 64 | 23% |
Unspecified | 37 | 13% |
Medicine and Dentistry | 31 | 11% |
Neuroscience | 5 | 2% |
Other | 18 | 6% |
Unknown | 60 | 21% |